This paper reviews the use of mesenchymal stem cell-derived exosomes in the treatment of pulmonary (lung) diseases. The exosomes can reduce inflammation, support tissue repair, and modulate immune responses in conditions like COPD, pulmonary fibrosis, and acute lung injury.

This research is highly relevant for patients with chronic respiratory conditions seeking regenerative treatment options.

This is a research reference from our clinical library. Approved by the Chambers Clinic Team — last reviewed May 28, 2026.